Clinical Trials Logo

Filter by:
NCT ID: NCT05209594 Completed - Clinical trials for Adolescent Development

Evaluation of the Healthy Relationships Program for 2SLGBTQIA+ Youth

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The Healthy Relationships Program (HRP) for two-spirit, lesbian, gay, bisexual, trans, queer, intersex, and asexual (2SLGBTQIA+) Youth is a flexible and adaptable 17-session mental health promotion and healthy relationship program for gender, sexual, and romantic minority youth. It helps build resiliency and promote well-being among 2SLGBTQIA+ youth. It affirms, validates, and celebrates sexual and gender diversity, cultivates a caring and supportive community, and helps 2SLGBTQIA+ youth develop skills and strategies that promote healthy relationships. Investigators will evaluate the HRP for 2SLGBTQIA+ youth in 10 intervention and 10 comparison Genders and Sexualities Alliance/Gay-Straight Alliances (GSAs) in schools across Canada. GSA advisors (educators) at intervention schools will receive training in the program prior to implementation. GSA members (students in grades 9 to 12) at both intervention and comparison sites will participate in a survey at three time points: (1) pre-GSA programming survey at the beginning of the school year, (2) a post-GSA programming survey at the end of the school year, and (3) a follow-up survey at the beginning of the next school year. The primary outcome is social-emotional functioning.

NCT ID: NCT05209425 Completed - Vitamin D Clinical Trials

Pharmacokinetics Evaluation of Vitamin D Formulations

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate plasma concentrations of Vitamin D (25-hydroxyvitamin D; 1,25-dihydroxyvitamin D) of different Vitamin D formulations in healthy volunteers at two concentrations. Pharmacokinetic parameters (Serum 25(OH)D and 1,25(OH)2D ng/ml) are compared with those of a regular Vitamin D formulation and a new (microencapsulated) LipoMicel Vitamin D formulation. The secondary objective of this study is to evaluate safety blood parameters- The following blood parameters (serum levels) are checked: Alkaline Phosphatase, ALT, AST, Bilirubin, CRP, Creatinine, GGT. In addition, mineral levels-such as calcium, magnesium and phosphorus, potassium and sodium-are measured before and at the end of the study.

NCT ID: NCT05207423 Completed - Clinical trials for Non-small Cell Lung Cancer (NSCLC)

A Chart Review Study of Adults With Advanced NSCLC

EXTRACT
Start date: October 3, 2022
Phase:
Study type: Observational

The main aim is to see how treatment patterns and drugs might improve care for adults with advanced or metastatic NSCLC with epidermal growth factor receptor (EGFR) exon-20 driven mutations. Past medical records will be reviewed. No clinic visits or procedures will be required.

NCT ID: NCT05206253 Completed - Muscle Atrophy Clinical Trials

Effectiveness of Egg Versus Whey Protein Powder During Resistance Training

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

Consumption of whole eggs has recently been shown to stimulate muscle protein synthesis to a greater degree than consumption of egg whites after a resistance training session. It is theorized that the egg yoke contains bio-active nutrients that enhance the protein provided by egg whites. The study will evaluate the effect of whole egg powder compared to whey protein powder and placebo over 12 weeks of resistance training in men and women who are participating in resistance training programs.

NCT ID: NCT05205538 Completed - Exercise Clinical Trials

Does Biological Sex Influence the Cardiac Output Response to Sprint Interval Exercise Training in Humans?

Start date: January 25, 2022
Phase: N/A
Study type: Interventional

Sprint interval exercise training refers to brief repeated bouts of vigorous effort that are separated by short periods of recovery. Cardiac output refers to the amount of blood that is pumped out of the heart each minute. Research has shown that sprint interval exercise training can increase peak cardiac output - or the highest cardiac output that is achieved during strenuous exercise - but this response may be influenced by biological sex. The primary goal of this study is to determine whether the peak cardiac output response to 12 weeks of sprint interval exercise training differs between males and females. Cardiac output will be estimated using a non-invasive technique that involves breathing in a mixture of standardized gases. This research will help to determine whether biological sex influences the response of the heart to brief vigorous cycle exercise training.

NCT ID: NCT05203653 Completed - Type 1 Diabetes Clinical Trials

Effectiveness of Aerobic Exercise to Mitigate Hyperglycemia After Fasted Resistance Exercise

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Certain types and timings of exercise are known to cause hyperglycemia (high blood glucose) in people with type 1 diabetes. Hyperglycemia increases the risk of most long-term complications for individuals with this complication. However, using insulin corrections to treat post-exercise hyperglycemia can increase the risk of late-onset hypoglycemia (low-blood glucose). Anaerobic activities performed in a fasted state are known to cause increases in blood glucose and post-exercise hyperglycemia in most individuals with type 1 diabetes. This study proposes to examine the effect of a ten-minute aerobic cool down after resistance exercise on the blood glucose response to fasted exercise of individuals with type 1 diabetes. It is hypothesized that adding a short aerobic cool down at the end of a fasted resistance exercise session will attenuate post-exercise increases in blood glucose observed in previous studies, leading to less post-exercise hyperglycemia.

NCT ID: NCT05199714 Completed - Type 1 Diabetes Clinical Trials

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

FCL
Start date: February 21, 2022
Phase: N/A
Study type: Interventional

The investigators aim to assess the glycemic outcomes of a fully automated insulin-and-pramlintide artificial pancreas and a comparator insulin-alone artificial pancreas with carbohydrate matched boluses.

NCT ID: NCT05199428 Completed - Clinical trials for Coronary Artery Disease

Optina Eye to Heart Connection

Start date: June 15, 2022
Phase:
Study type: Observational

This is a prospective cross-sectional, single-center retinal imaging study expecting to enroll approximately 400 male and female subjects ≥ 18 years of age. Subjects having undergone clinically-indicated coronary angiography or coronary computed tomography angiography (CCTA) within one month of consent at the Montreal Heart Institute (MHI) will be screened for inclusion in the study.

NCT ID: NCT05197803 Completed - Hearing Loss Clinical Trials

Clinical Study of Released Unitron RIC and BTE Hearing Aid Models

Start date: January 4, 2022
Phase: N/A
Study type: Interventional

Participants will wear two sets of Unitron released hearing aids (RIC and BTE) programmed based on a prescriptive approach and will perform a standardized speech discrimination test in noise in both aided conditions as well as in unaided condition.

NCT ID: NCT05197244 Completed - Osteoporosis Risk Clinical Trials

A Culinary Intervention for Bone Health

Start date: July 15, 2022
Phase: N/A
Study type: Interventional

This is a randomized, controlled pilot study to evaluate the feasibility and acceptability of a single 2-hour culinary medicine intervention for bone health among individuals with age-associated low bone mass.